| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.04 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.093 | 0.05 |